SIHUAN PHARM(00460),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

00460 SIHUAN PHARM

Closed The day following the Chung Yeung Festival 10-16 16:08:16

0.705

+0.010

+1.44%

High0.720	Low0.695	Vol17.95M
Open0.700	D1 Closing0.695	Amplitude3.60%
Mkt Cap6.43B	Tradable Cap6.43B	Total Shares9.12B
T/O12.70M	T/O Rate0.20%	Tradable Shares9.12B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"00460","market":"HK","secType":"STK","nameCN":"SIHUAN PHARM","latestPrice":0.705,"timestamp":1792138096002,"preClose":0.695,"halted":0,"volume":17952334,"delay":0,"changeRate":0.014388489208633108,"floatShares":9116000000,"shares":9116000000,"eps":0.0197,"marketStatus":"Closed The day following the Chung Yeung Festival","change":0.01,"latestTime":"10-16 16:08:16","open":0.7,"high":0.72,"low":0.695,"amount":12695070,"amplitude":0.035971,"askPrice":0.705,"askSize":713000,"bidPrice":0.695,"bidSize":538000,"shortable":3,"etf":0,"ttmEps":0.038573,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1792459800000},"marketStatusCode":7,"adr":0,"listingDate":1288195200000,"exchange":"SEHK","adjPreClose":0.695,"dividendRate":0.015928,"openAndCloseTimeList":[[1792114200000,1792123200000],[1792126800000,1792137600000]],"volumeRatio":0.9491306321754404,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00460/wiki","defaultTab":"wiki","newsList":[{"id":"1114675251","title":"Hong Kong Regulators Issue Joint Statement on Audit Opinions; Nasdaq Slides 1.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114675251","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114675251?lang=en_us&edition=fundamental","pubTime":"2026-10-09 08:02","pubTimestamp":1791504126,"startTime":"0","endTime":"0","summary":"Hong Kong's Securities and Futures Commission, the Accounting and Financial Reporting Council, and the Stock Exchange of Hong Kong have issued a joint statement addressing growing regulatory concerns...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177","BK1522","00189","BK1580","01748","IE00BZ08YT58.USD","LU1064130708.USD","LU1064131003.USD","LU1242518857.USD","BK1593","BK1511","LU0516423174.USD","LU0516422440.USD","BK1589","BK1610","LU0871576103.HKD","LU0228367735.SGD","LU0531971595.HKD","02026","06887","BK1129","00460","LU0979878070.USD","LU0516422366.SGD","LU0164865239.USD","LU0516422952.EUR","LU2148510915.USD","06055","LU0149721374.USD","02720","BK1528","PONY","BK1213","BK1191","LU0516423091.SGD","BK1515","BK1521","IXIC","BK1594","HK0000165453.HKD","BK1238","SG9999001093.SGD","LU0163747925.USD","SBHMY","LU0164880469.USD","BK1103","BK1181","BK1109","LU0039217434.USD","600938","LU1242518931.SGD","BK1502","FRCOY","00883","80883","BK1600","BK1114","LU1481107354.HKD","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","06288"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177960521","title":"SIHUAN PHARM Makes Strategic Investment in Hanteng Biotech to Complete Regenerative Medical Aesthetics Industry Chain","url":"https://stock-news.laohu8.com/highlight/detail?id=1177960521","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177960521?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:56","pubTimestamp":1791464176,"startTime":"0","endTime":"0","summary":"SIHUAN PHARM (00460) has announced that its subsidiary Meiyan Space Biotechnology (Jilin) Co., Ltd. (Meiyan Space) has completed a strategic equity investment in Guangzhou Hanteng Biotechnology Co.,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","00460","BK1515","BK1600","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673635077","title":"Sihuan Pharma - Unit Completes Strategic Equity Investment in Canton Biologics","url":"https://stock-news.laohu8.com/highlight/detail?id=2673635077","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673635077?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:42","pubTimestamp":1791463373,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nFWN45U1S7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","BK1600","BK1191","BK1593","00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673709413","title":"Sihuan Pharma Unit Gets China Nod for Five New Specifications of Skin Booster","url":"https://stock-news.laohu8.com/highlight/detail?id=2673709413","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673709413?lang=en_us&edition=fundamental","pubTime":"2026-10-05 18:13","pubTimestamp":1791195199,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical  said five new specifications of the Hyaluronic Acid Sodium Composite Solution for Injection were approved for launch by China's National Medical Products Administration.The composite solution skin booster was developed by unit Meiyan Space Biotechnology , a Monday bourse filing showed.The specification expansion will allow adaptation to diverse skin needs and clinical application scenarios among other benefits.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","BK1600","BK1515","00460","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108727369","title":"SIHUAN PHARM (00460): Additional Specifications of \"Dongyan\" Skin Booster Approved for Market Launch by National Medical Products Administration","url":"https://stock-news.laohu8.com/highlight/detail?id=1108727369","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108727369?lang=en_us&edition=fundamental","pubTime":"2026-10-05 17:08","pubTimestamp":1791191297,"startTime":"0","endTime":"0","summary":"SIHUAN PHARM (00460) has announced that five additional specifications of its self-developed sodium hyaluronate composite solution for injection (skin booster, trade name: Dongyan), developed by its...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1600","BK1593","BK1515","00460","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673054037","title":"Sihuan Pharma - Five New Specifications of Dongyan Skin Booster Approved for Launch by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2673054037","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673054037?lang=en_us&edition=fundamental","pubTime":"2026-10-05 16:56","pubTimestamp":1791190581,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45Q03V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1515","BK1600","BK1593","00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154442713","title":"Sihuan Pharmaceutical Announces Release of Interim Report 2026 and Details Shareholder Communication Procedures","url":"https://stock-news.laohu8.com/highlight/detail?id=1154442713","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154442713?lang=en_us&edition=fundamental","pubTime":"2026-09-16 17:06","pubTimestamp":1789549613,"startTime":"0","endTime":"0","summary":"The board of Sihuan Pharmaceutical has issued a formal notice confirming that the company’s Interim Report 2026 is now available on both the corporate website (www.sihuanpharm.com) and Hong Kong...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183875811","title":"SIHUAN PHARM Publishes 2026 Interim Report and Updates Shareholder Communication Arrangements","url":"https://stock-news.laohu8.com/highlight/detail?id=1183875811","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183875811?lang=en_us&edition=fundamental","pubTime":"2026-09-16 17:03","pubTimestamp":1789549396,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd. (SIHUAN PHARM) released formal notice that its Interim Report 2026 is now available on the company’s website and on HKExnews. Shareholders can access the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147275877","title":"SIHUAN PHARM Subsidiary Xuanzhu Biopharm Seals Thailand Deal Granting Innobic Exclusive Rights to Commercialise Bireociclib Until 2036","url":"https://stock-news.laohu8.com/highlight/detail?id=1147275877","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147275877?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:24","pubTimestamp":1788427466,"startTime":"0","endTime":"0","summary":"Hong Kong-listed Sihuan Pharmaceutical Holdings Group Ltd. (SIHUAN PHARM) announced that its non-wholly-owned subsidiary, Xuanzhu Biopharmaceutical Co., Ltd. (02575.HK), has entered into a tri-party...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664878574","title":"Sihuan Pharma Affiliate Xuanzhu Biopharm Grants Innobic Exclusive Thailand Commercialization Rights for Bireociclib Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=2664878574","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664878574?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:18","pubTimestamp":1788427127,"startTime":"0","endTime":"0","summary":"Sihuan Pharma affiliate Xuanzhu Biopharm grants Innobic exclusive Thailand commercialization rights for Bireociclib tabletsSihuan Pharmaceutical’s non-wholly owned unit Xuanzhu Biopharm granted exclus","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL8K9jwT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","02575","BK1515","BK1191","BK1593","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664851528","title":"Sihuan Pharma Grants 116,150,000 Share Awards Under 2026 Incentive Scheme at HK$ 0.74 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2664851528","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664851528?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:58","pubTimestamp":1788267535,"startTime":"0","endTime":"0","summary":"Sihuan Pharma grants 116,150,000 share awards under 2026 incentive scheme at HK$ 0.74 eachSihuan Pharmaceutical launched a 2026 share award grant covering 116,150,000 shares, about 1.27% of issued sha","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL9s25cf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","00460","BK1191","BK1593","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662084715","title":"Sihuan Pharmaceutical (SEHK:460) Stock Price Lags Profit Recovery as Valuation Stretches","url":"https://stock-news.laohu8.com/highlight/detail?id=2662084715","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662084715?lang=en_us&edition=fundamental","pubTime":"2026-08-27 22:24","pubTimestamp":1787840647,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group entered these results following a period of weak share price performance, with the stock down over the past week, month and quarter, yet trading on a rich P/E of 21x. That is a set up for emotional trading. The headline from this half year is simple. Profitability has firmed up, with basic earnings per share at C¥0.0249 on revenue of C¥1,161.2m. The tug of war now is between investors who are concerned about the valuation strain and those who see a company...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-460/sihuan-pharmaceutical-holdings-group-shares/news/sihuan-pharmaceutical-sehk460-stock-price-lags-profit-recove","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-460/sihuan-pharmaceutical-holdings-group-shares/news/sihuan-pharmaceutical-sehk460-stock-price-lags-profit-recove","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1191","BK1515","BK1600","BK1593","00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185317758","title":"Sihuan Pharmaceutical Announces HK$8.11 Million Share Buy-Back; H1 2026 Net Profit Surges 221%","url":"https://stock-news.laohu8.com/highlight/detail?id=1185317758","media":"Bulletin Express","labels":["shareholding","dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185317758?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:22","pubTimestamp":1787833344,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharmaceutical) has executed an on-market repurchase of 10.00 million shares on 27 August 2026 under the general mandate approved at the 6 June 2025...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187566550","title":"SIHUAN PHARM Repurchases 10 Million Shares for HK$8.11 Million, Lifting Treasury Stock to 214 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1187566550","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187566550?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:41","pubTimestamp":1787827318,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd. (SIHUAN PHARM) disclosed that it bought back 10.00 million ordinary shares on 27 August 2026 through on-exchange transactions. • Transaction details: The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662705289","title":"Sihuan Pharma Files HKEX Next-Day Return Disclosing Share Repurchase at HKD 0.81","url":"https://stock-news.laohu8.com/highlight/detail?id=2662705289","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662705289?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:34","pubTimestamp":1787826855,"startTime":"0","endTime":"0","summary":"Sihuan Pharma files HKEX next-day return disclosing share repurchase at HKD 0.81Sihuan Pharmaceutical repurchased 10,000,000 ordinary shares on Aug. 27, holding all as treasury shares.Buyback price ra","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL6cXYkS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1600","BK1593","BK1515","00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662717592","title":"Grand Pharmaceutical H1 Revenue Rises on Nuclear Medicine Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2662717592","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662717592?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:54","pubTimestamp":1787752465,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical H1 revenue rises on nuclear medicine demandOverviewHong Kong-listed pharma group's H1 revenue rose 3.2% yr/yr to HK$6.39 blnNet income attributable to owners fell to HK$1.06 bln f","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N0MX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK1515","00512","BK1191","BK1583","BK1600","03692","BK1589","00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662715194","title":"China's Zhongzhi Pharmaceutical H1 Revenue Falls 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662715194","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662715194?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:36","pubTimestamp":1787744170,"startTime":"0","endTime":"0","summary":"China's Zhongzhi Pharmaceutical H1 revenue falls 10%OverviewChina pharmaceutical maker's half-year revenue fell 10.3% yr/yrProfit attributable to owners rose 3.8% yr/yrGross profit and margin declined","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N0G0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","00460","01681","BK1583","03692","BK1600","BK1606","03737","BK1191","BK1515","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662973617","title":"Sihuan Pharma FY26 H1 Profit Attributable to Owners Rises 119% to RMB 224.7 Million; Revenue Increases 1.3% to RMB 1.16 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2662973617","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662973617?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:08","pubTimestamp":1787738933,"startTime":"0","endTime":"0","summary":"Sihuan Pharma FY26 H1 profit attributable to owners rises 119% to RMB 224.7 million; revenue increases 1.3% to RMB 1.16 billionSihuan Pharmaceutical posted profit attributable to owners of RMB 224.7 m","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDLc1wDYT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","00460","BK1600","BK1593","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662794653","title":"Sihuan Pharmaceutical Files Board, Committee Roles and Disclosure-Responsible Management List","url":"https://stock-news.laohu8.com/highlight/detail?id=2662794653","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662794653?lang=en_us&edition=fundamental","pubTime":"2026-08-26 17:38","pubTimestamp":1787737093,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical files board, committee roles and disclosure-responsible management listSihuan Pharmaceutical named Che Fengsheng as chairman; Guo Weicheng as vice chairman, chief executive; exec","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL1yGHl8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","BK1515","00460","BK1191","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191993997","title":"SIHUAN PHARM Posts 119% Profit Surge in Interim Results, Reinforcing Dual-Engine Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=1191993997","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191993997?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:36","pubTimestamp":1787718981,"startTime":"0","endTime":"0","summary":"SIHUAN PHARM (00460) has reported its interim results for the six months ended June 30, 2026, showcasing a substantial jump in profitability. The group recorded a total revenue of RMB 1.161 billion,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","BK1161","06978","159992","BK1515","LNGR","IBBQ","MEDX","BK1574","00460","BK1191","BK1593"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sihuanpharm.com.cn","stockEarnings":[{"period":"1week","weight":-0.0473},{"period":"1month","weight":-0.007},{"period":"3month","weight":-0.1802},{"period":"6month","weight":-0.4635},{"period":"1year","weight":-0.5303},{"period":"ytd","weight":-0.4198}],"compareEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":-0.0213},{"period":"3month","weight":-0.0153},{"period":"6month","weight":-0.0754},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":-0.0563}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company primarily engaged in the research and development, manufacture and sale of pharmaceutical products and aesthetic products. The Company operates its business through three segments. The Medical Aesthetic Products segment includes the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetic comprehensive solutions. The Innovative Medicine and Other Medicine segment is engaged in the research and development and commercialization of innovative medicine in the disease fields of diabetes, breast cancer, digestion disorders, oncology and non-alcoholic steatohepatitis and others. The Generic Medicine segment is engaged in the production and sale of generic medicine including Kelin’ao and other products. The Company conducts its business in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.119713},{"month":2,"riseRate":0.5,"avgChangeRate":0.000651},{"month":3,"riseRate":0.3125,"avgChangeRate":-0.032043},{"month":4,"riseRate":0.533333,"avgChangeRate":0.038601},{"month":5,"riseRate":0.4,"avgChangeRate":0.003084},{"month":6,"riseRate":0.533333,"avgChangeRate":-0.005353},{"month":7,"riseRate":0.6,"avgChangeRate":0.012776},{"month":8,"riseRate":0.466667,"avgChangeRate":-0.024743},{"month":9,"riseRate":0.2,"avgChangeRate":-0.043907},{"month":10,"riseRate":0.533333,"avgChangeRate":0.025465},{"month":11,"riseRate":0.466667,"avgChangeRate":0.008336},{"month":12,"riseRate":0.4,"avgChangeRate":-0.017751}],"exchange":"SEHK","name":"SIHUAN PHARM","nameEN":"SIHUAN PHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SIHUAN PHARM(00460),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SIHUAN PHARM(00460) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SIHUAN PHARM,00460,SIHUAN PHARM股票,SIHUAN PHARM股票老虎,SIHUAN PHARM股票老虎国际,SIHUAN PHARM行情,SIHUAN PHARM股票行情,SIHUAN PHARM股价,SIHUAN PHARM股市,SIHUAN PHARM股票价格,SIHUAN PHARM股票交易,SIHUAN PHARM股票购买,SIHUAN PHARM股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SIHUAN PHARM(00460),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SIHUAN PHARM(00460) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}